Cargando…

Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry

BACKGROUND: Thrombocytopenia is associated with increased mortality in the general population, but few data exist in patients with atrial fibrillation (AF) taking oral anticoagulants. We investigated factor determinants of thrombocytopenia in a large cohort of patients affected by AF and its associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pastori, Daniele, Antonucci, Emilia, Violi, Francesco, Palareti, Gualtiero, Pignatelli, Pasquale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898797/ https://www.ncbi.nlm.nih.gov/pubmed/31656119 http://dx.doi.org/10.1161/JAHA.119.012596

Ejemplares similares

Clinical Phenotypes of Atrial Fibrillation and Mortality Risk—A Cluster Analysis from the Nationwide Italian START Registry
por: Pastori, Daniele, et al.
Publicado: (2022)

The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation
por: Antonucci, Emilia, et al.
Publicado: (2015)

Tailored Practical Management of Patients With Atrial Fibrillation: A Risk Factor-Based Approach
por: Pastori, Daniele, et al.
Publicado: (2019)

Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms
por: Violi, Francesco, et al.
Publicado: (2016)

Comparison of Anticoagulation Quality between Acenocoumarol and Warfarin in Patients with Mechanical Prosthetic Heart Valves: Insights from the Nationwide PLECTRUM Study
por: Menichelli, Danilo, et al.
Publicado: (2021)

Age-related increase of thromboxane B(2) and risk of cardiovascular disease in atrial fibrillation
por: Pastori, Daniele, et al.
Publicado: (2016)

Aging‐Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation
por: Pastori, Daniele, et al.
Publicado: (2016)

Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Advanced Liver Disease: An Exploratory Meta‐Analysis
por: Violi, Francesco, et al.
Publicado: (2020)

Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study
por: Poli, Daniela, et al.
Publicado: (2019)

Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry
por: Marcucci, Rossella, et al.
Publicado: (2019)

Non-alcoholic fatty liver disease (NAFLD), metabolic syndrome and cardiovascular events in atrial fibrillation. A prospective multicenter cohort study
por: Pastori, Daniele, et al.
Publicado: (2021)

Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register
por: Poli, Daniela, et al.
Publicado: (2022)

Gut‐Derived Serum Lipopolysaccharide is Associated With Enhanced Risk of Major Adverse Cardiovascular Events in Atrial Fibrillation: Effect of Adherence to Mediterranean Diet
por: Pastori, Daniele, et al.
Publicado: (2017)

Digoxin and Platelet Activation in Patients With Atrial Fibrillation: In Vivo and In Vitro Study
por: Pastori, Daniele, et al.
Publicado: (2018)

SARS-CoV-2 and myocardial injury: a role for Nox2?
por: Violi, Francesco, et al.
Publicado: (2020)

Thrombosis in pre- and post-vaccination phase of COVID-19
por: Violi, Francesco, et al.
Publicado: (2021)

Data on incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
por: Pastori, Daniele, et al.
Publicado: (2018)

Interaction Between Dietary Vitamin K Intake and Anticoagulation by Vitamin K Antagonists: Is It Really True?: A Systematic Review
por: Violi, Francesco, et al.
Publicado: (2016)

Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study
por: Violi, Francesco, et al.
Publicado: (2015)

PCSK9 Regulates Nox2-Mediated Platelet Activation via CD36 Receptor in Patients with Atrial Fibrillation
por: Cammisotto, Vittoria, et al.
Publicado: (2020)

Treatment Decision-Making of Secondary Prevention After Venous Thromboembolism: Data From the Real-Life START2-POST-VTE Register
por: Antonucci, Emilia, et al.
Publicado: (2020)

Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants
por: Testa, Sophie, et al.
Publicado: (2019)

Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management
por: Pignatelli, Pasquale, et al.
Publicado: (2020)

Total Adiponectin Is Inversely Associated with Platelet Activation and CHA(2)DS(2)-VASc Score in Anticoagulated Patients with Atrial Fibrillation
por: Carnevale, Roberto, et al.
Publicado: (2014)

Aging-Related Decline of Autophagy in Patients with Atrial Fibrillation—A Post Hoc Analysis of the ATHERO-AF Study
por: Versaci, Francesco, et al.
Publicado: (2022)

Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome
por: Patti, Giuseppe, et al.
Publicado: (2017)

Risk of reoperation in bioprosthetic valve patients with indication for long-term anticoagulation. Results from the observational retrospective multicentre PLECTRUM study
por: Poli, Daniela, et al.
Publicado: (2018)

Multiple Arterial Thrombosis in Seronegative Antiphospholipid Syndrome: Need for New Diagnostic Criteria?
por: Pastori, Daniele, et al.
Publicado: (2019)

Mediterranean Diet: A Tool to Break the Relationship of Atrial Fibrillation with the Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
por: Biccirè, Flavio Giuseppe, et al.
Publicado: (2022)

Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register
por: Palareti, Gualtiero, et al.
Publicado: (2021)

Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register
por: Palareti, Gualtiero, et al.
Publicado: (2020)

Circulating Lipopolysaccharides and Impaired Antioxidant Status in Patients With Atrial Fibrillation. Data From the ATHERO-AF Study
por: Menichelli, Danilo, et al.
Publicado: (2021)

Mortality risk and temporal patterns of atrial fibrillation in the nationwide registry
por: Apiyasawat, Sirin, et al.
Publicado: (2021)

Vitamin E Serum Levels and Bleeding Risk in Patients Receiving Oral Anticoagulant Therapy: a Retrospective Cohort Study
por: Pastori, Daniele, et al.
Publicado: (2013)

Epidemiology, diagnosis, and management of atrial fibrillation in women
por: Poli, Daniela, et al.
Publicado: (2015)

Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It
por: Palareti, Gualtiero
Publicado: (2012)

Management and Outcomes of Isolated Distal Deep Vein Thromboses: A Questionable Trend toward Long-Lasting Anticoagulation Treatment. Results from the START-Register
por: Palareti, Gualtiero, et al.
Publicado: (2021)

Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-COVID Register
por: Poli, Daniela, et al.
Publicado: (2022)

Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses
por: Gazzaniga, Gianluca, et al.
Publicado: (2023)

Association between right ventricular dysfunction and adverse cardiac events in mild COPD patients
por: Armentaro, Giuseppe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r77q1pnq894sd4q8bq8lgs6mqk